Skip to main content

Letrozole (International)

In the US, Letrozole (letrozole systemic) is a member of the following drug classes: aromatase inhibitors, hormones/antineoplastics and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic and Female Infertility.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02BG04

CAS registry number (Chemical Abstracts Service)

0112809-51-5

Chemical Formula

C17-H11-N5

Molecular Weight

285

Therapeutic Category

Antineoplastic agent: Nonsteroidal aromatase inhibitor

Chemical Name

Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmetylene)bis-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs